| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Improved survival with ipilimumab in patients with metastatic melanoma. | N Engl J Med | 2010 | 67.34 |
| 2 | A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma. | Invest New Drugs | 2010 | 2.09 |